Integrated solutions for cannabis based and natural formulations, extracts and product development from concept to market delivery.
Through a Strategic Partnership in which Abattis owns 10% of XLABS, Abattis and XLABS will be launching a new cannabis laboratory in Belleville, Ontario, to service Ontario’s growing cannabis sector. The Laboratory will be housed in a 320,000 square foot building, with plans for an initial build-out of 10,000 square feet and future expansion into the remaining 310,000 square feet through organic growth and further joint ventures. The Belleville Facility has been deemed suitable for use as a medical cannabis research facility under Health Canada’s Narcotic Control Regulations by an independent consultant engaged by XLABS.
The mission of XLABS is to become the world’s best and Canada’s largest company dedicated to the production, management and distribution of premium cannabinoid-containing oils and isolates with API (Active Pharmaceutical Ingredient) grade purity, from in-situ extraction and purification to high security storage, as well as brokerage services including importation, sales and distribution of high purity oils and isolates across Canada and around the world. Our laboratories follow strict standard operating protocols and adhere to the applicable laws of Canada and foreign jurisdictions
Abattis Bioceuticals is well positioned to provide a full suite of downstream services to these products and the thousands of products that will come online as recreational and medicinal legalization laws progress in Canada and internationally
There are over 255 legal marijuana or cannabis based businesses producing 2,200+ products.
Abattis Bioceuticals is perfectly positioned to provide a full suite of downstream services to these products and the thousands of products that will come online as recreational and medicinal legalization laws progress in Canada and Internationally.
Follow our progress on social media and look for our new product developments and releases.